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Abstract. Behavioral changes resembling human athetoid and choreiform hyper- 
kinesias were produced b y  unilateral injections of L-3,4-dihydroxyphenylalanine 
(l-D O P A ), dopamine, 3-m ethoxy-tyram ine and dexamphetamine into the rostrome- 
dial part of the caput caudati o f ca ts; saline, noradrenaline and 3,4 -dihydroxyphe- 
nylacetio acid were ineffective. Pretreatment with the tyrosine hydroxylase inhibi- 
tor, oc-methyl-para-tyrosine, blocked the effects induced b y  l-D O P A , dopamine and  
dexamphetamine in a competitive w ay; the 3-methoxy-tyramine effect was blocked 
in a non-competitive w ay. Applications o f the active compounds into the antero- 
ventral paft o f the caput caudati were ineffective.
The hypothesis is put forward th a t normally dopamine-sensitive sites are 
involved in the manifestation o f choreo-athetoid movements. The implications of  
these findings are oonsidered in view o f the efficacy of l -D O P A  and a-m ethyl-D O PA  
in Parkinson’a disease and Huntington’s chorea, respectively. In  addition, our data  
are discussed in the light o f the recent finding th at lesions restricted to the antero- 
ventral part of the caput caudati also résult in these hyperkinesias.
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Introduction
Since Ehringer and Homykiewicz reported in 1960 that the con- 
centration of dopamine in the neostriatum and globus pallidus is 
reducsed in parkinsonism, considerable interest has developed in the 
neurochemistry of the underlying disorder. A t the present time, the 
introduction of L-3,4-dihydroxyphenylalanine (l-DOPA) appears to be 
the most important advance in the treatment of Parkinson’s disease 
(Klawans, Ilahi and Shenker, 1970b). Long-term l-D O PA  therapy 
improves the bradykinesia, rigidity, loss of postural reflexes and to 
a lesser extent the tremor of parkinsonism (Cotzias, Papavasiliou and 
Gellene, 1969; Yahr, Duvoisin, Schear, Barrett and Hoehn, 1969). In 
view of the essential role of dopamine in the caudate nucleus (Horny- 
kiewicz, 1966), it is generally accepted that the therapeutic efïicacy of 
l-D O PA  is due to the replacement of dopamine in the basal ganglia by 
exogeneous dopamine derived from l-D O PA  (Klawans, 1968).
However, l-DOPA  treatment is not without sidé-eiFects: in a sig­
nificant number of patients extremely severe choreo-athetoid movements
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are seen after long-term treatment (Yahr et al., 1969; Papavasiliou, 
Gellene and Cotzias, 1969). Choreo-athetoid movements are generally 
imputéd to structures such as the subthalamic nucleus, putamen, 
nucleus accumbens septi and brachium conjunctivum. Papavasiliou et al. 
(1969), therefore, suggested that the side-effects secondary to long-term 
treatment of l-D O PA  only develop when excesses of dopamine enter 
neurons from which they are ordinarily excluded; their arguments are 
in favor of normally dopamine-insensitive sites as the target sites of 
these side-effects.
On the other hand, in a report describing the behavioral effects of 
small lesions in cats, Liles and Davis (1969a) provided the information 
that the caudate nucleus itself ia involved in choreo-athetoid hyper-
kinesias.
In view of these findings the hypothesis may be put forward that 
the normally dopamine-sensitive sites are also involved as the target 
sites of the choreo-athetoid movements.
In former experiments it was shown that dopamine, administered 
unilaterally into the caudate nucleus of cats, induced a stereotyped 
behavior marked by a decrease of specific units such as lieking and 
cleaning, by a decrease of dynamic units such as standing and walking 
and by stereotyped movements of the head and the limbs (Cools and 
van Rossum, 1970; Cools, 1971) .
In view of the mentioned considerations the present study was 
designed to examine in more detail the temporal patteming of the 
induced limb movements.
Methodg
A  detailed account of the experimental technique has already been 
published (Cools and van Rossum, 1970). Briefly, double barrelled can- 
nulae were stereotaxically implanted into the brain of male cats. Upon 
complete recovery from the operation, small quantities of drug solutions 
(10 (jlI) were injected through the injection needle which extended into 
the brain tissue 2 mm below the tip of the embedded cannulae. Since 
it has been shown that dopamine application is ineffective in all caudate 
areas except from the caput caudati rostromedialis (Cools et al., 1970), 
brain site co-ordinates for placements discussed in this paper included 
this area (A14_16, L4_6, H14_16) and the caput caudati anteroventralis 
(A17_19, Ls_5, H13_15) which was used as a control area (ïïg . 1).
The following substances were injected: saline(placebo),L-DOPA-IlCl, 
dopamine-HCl,3-methoxy-tyramine-HCl,noradrenaline-HCl,3,4-dihydro- 
xyphenylacetic acid(DOPAC) and dexamphetamine-HjS0 4; all drugs 
were dissolved in saline and adjusted to pH 4—5. In additional èxperi- 
ments pretreatment with the tyrosine hydroxylase inhibitor, «-methyl-
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para-tyrosine («-MT), was given in order to test the specificity of the 
induced effects; 20 min prior to the application of dopamine or related 
compounds 20 (ig a-MT was injected locally. The temporal patterning 
of the limbs was recorded during a period of 45 min divided into nine 
time test-blocks, 5 min each: three before and six after the injection. 
In each six animals (12 injection-loci) were used.
Results
In general, the abnormal limb movements following an injection of 
10 (ig dopamine into the caput caudati rostromedialis could be divided 
into two groups:non-patterned movements in vol ving the distal part of 
the limb and non-pattemed movements involving the entire limb.
A. Non-pattemed movements involving the distal part of the limb.
When the animal was standing, sitting or lying on its side, these 
movements began slowly: the limb was lifted from the floor for a couple 
of seconds and the paw and toes underwent alternating hyperextension 
and flexion movements. The alternating rhythinic ventriflexions and
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dorsiflexions were slow pattems rather ihan isolated acts and occurred 
either at rest of in the course of a voluntary action; in the last case the 
animal stopped the performance of the voluntary action when the move­
ments appeared. On many occasions the appearance was accompanied by 
piloerection and curling of the tail. The whole pattem was purposeless, 
non-adaptive and compulsive in character. It occurred independently 
of the ongoing activity of the animal and the animal itself had no visual 
interest in the induced patteming of its limb. The activity was restricted 
to the forélimb contralateral to the injection site in case of DOPA, 
dopamine and 3-methoxy-tyramine; it was alternating from one fore- 
limb to the other in case of dexamphetaimne.
B. Non-patterned movements involving the entire limb.
These movements occurred only when the animal was standing or 
sitting. Usually, they followed up or interrupted the above-mentioned 
movements. The limb was lifted from the floor and it showed rapid, 
jerky, shaking-off movements involving the entire limb; these move­
ments were repeated several times in an irregular way. The series of 
abrupt, gross irregular movements was violent and choreiform in nature. 
Apart from the fact that the animal had continuous visual interest in 
these movements, it began to clean and to lick the affected limb in an 
intense way, when the movements disappeared. These choreiform move­
ments were induced not only in the forélimb contralateral to the injec­
tion site, but also in the hindlimb homolateral to the injection site.
In general, both kinds of movements appeared as episodes of which 
the frequenoy had a maximum in the middle of the first 5-min period 
foliowing the injection; at some times the choreiform movements were 
also present in the second and third 5-min period. The involuntary 
and irregular movements of the limbs were always elicited by small 
doses (10 [Ag) of DOPA, dopamine, 3-methoxy-tyramine and dexamphet- 
amine administered into the caput caudati rostromedialis. No limb 
movements were noted when saline (placebo), noradrenaline or DOP AC 
were applied (Table 1); even high doses (80 [Ag) were ineffective. The 
most effective dose of DOPA and dopamine was 25 [Ag and 80 [Ag, re- 
spectively; 3-methoxy-tyramine was equally effective in spite of the 
dose (10 [Ag— 80 [Ag). The effect of dexamphetamine was markedly in- 
creased in comparison with the maximum effect of dopamine; not only 
the intensity of the movements was increased, but also the episode itself 
was prolonged. However, extending the dose range from 10 [Ag to 
144 [Ag yielded no further increase in effeot.
Of the brain areas sampled, the movements were. always elicited 
from the caput caudati rostromedialis, although the intensity and fre- 
quency varied considerably between animals. Animals in which the
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Table 1. Quantitative aspects of the athetoid and choreiform episodes in the cat after 
microinjections into the rostromedial part of the caput caudatia. Numbers of episodes 
are average rates: 0 =  none-, = 1— 3; 2= 4— 6; 3 >  7
Compounds
dose post injection time intervals (min)
([ig/10 jxl) 0 - 1 l 2 - ! i  4 - 5 6 - 1 0 1 1 -1 5
l -D O P A 10.0 0 1 1 0 0
25.0 0 2 1 1 0
dopamine 10.0 0 1 0 0 0
80.0 0 2 1 1 0
D O P A C 10.0 0 0 0 0 0
80.0 0 0 0 0 0
3 -methoxytyramine 10.0 0 1 1 0 0
80.0 0 1 1 0 0
noradrenaline 10.0 0 0 0 0 0
80.0 Ó 0 0 0 0
dexamphetamine 10.0 0 3 2 1 1
144.0 0 3 2 1 1
saline 0.09 0 0 0 0 0
•  The number o f limb movements are varying from 1—10 per episode.
compounds were administered into the caput caudati anteroventralis 
sometimes exhibited these movements; i f  present, the latency of their 
appearance was increased from 2—3 min to 20—24 min and the 
frequency was strongly decreased. When a-MT was given 20 min 
prior to the effective compounds, the limb movements induced by low 
doses (10 (A g ) of DOPA, dopamine, 3-methoxy-tyramine and dexam- 
phetamine were totally suppressed. High doses (80 [Ag) of only DOPA, 
dopamine and dexamphetamine surmounted the inhibition and induced 
the originally élicited involuntary and irregular pattems; in contrast, 
3-methoxy-tyramine remained ineffective in spite of high doses (80 fj.g).
Discussion
The non-pattemed movements involving the distal part of the limb 
and the non-pattemed movements involving the entire limb have to be 
determined as athetoid and choreiform movements respectively in 
reference to the terminology used b y Liles and Davis in their lesion 
study (1969 a). In fact, no distinguishable difFerences could be found 
between our observations and their detailed descriptions. However, 
small differences were noted with respect to the side of occurence: in 
the lesion study the athetoid movements normally appeared in both 
forelimbs, while they occasion ally occurred in the forelimb contralateral 
to the lesion site; in our study these movements were always restricted 
to the forelimb contralateral to the injection site in the case of DOPA,
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dopamine and 3-methoxy-tyramine, while they were altemating from 
one forelimb to the other in the case of dexamphetamine.
Although 3-methoxy-tyramine appeared to be just as effective as 
dopamine, the non-competitive inhibition of its effect by the dopamine- 
synthesis inhibitor, «-MT, and the ineffectiveness of the other dopamine 
metabolites, DOPAC and noradrenaline, indicate that the abnormal 
pattemings of the limb movements have to be regarded as “ dopamine- 
specific” effects; the effectiveness of high doses of only DOPA, dopamine 
and dexamphetamine following inhibition of the dopamine-synthesis 
strengthens this assumption.
The observation that dopamine and related compounds were only 
effective in the caput caudati rostromedialis is in agreement with óur 
previously reported finding that the dopamine-sensitive sites are re- 
stricted to the rostromedial area (Cools and van Rossum, 1970).
In regard to the data of Liles and Davis (1969a) the conclusion can 
be drawn that two cleariy distinct areas of the caudate nucleus are 
involved in these symptoms: the rostromedial area following dopamine 
application and the anteroventral area following electrolytic lesion. 
Since neither dopamine application into the anteroventral area nor 
lesion of the rostromedial area did lead to the mentioned hyperkinesias, 
these areas must have different functions. I t  has been shown that the 
head of the caudate nucleus represents localized functional regions: 
the inhibiting anteroventral region and the facilitating rostromedial 
region1 (Liles and Davis, 1969 b). In a previous report we have found 
evidence that dopamine in the rostromedial area might induce activa- 
tion of inhibiting neurons (Cools, 1971). In view of these findings it is 
reasonable to suggest that the dopamine-sensitive sites which are 
restricted to the caput caudati rostromedialis belong to very small 
inhibiting neurons which are projecting to the caput caudati anteroven- 
tralis; for activation of these intemeurons or lesion of the cell bodies 
controlled by these neurons results in the same effect. Although the 
nature of these intemeurons is so far unknown, extremely small caliber 
neurons have been observed previously in the head of the caput caudati 
(Adinolfi, 1967). Experiments in order to test this are in progress. 
The most important result, however, is the discovery that the choreo- 
athetoid hyperkinesias are elicited from the caudate nucleus in which 
dopamine normally occurs in terminal structures of nerve-endings (Fuxe, 
1965). Thus, activation or overactivation of normally dopamine-sen­
sitive sites leads to choreo-athetoid hyperkinesias.
In view of these data, the hypothesis can be put forward that nor­
mally dopamine-sensitive sites (of the caudate nucleus) are also involved
1 Rostromedial area correponds partially to the posterodoraal area o f Liles and 
Davis (1969a and b)
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as the target sites of choreo-athetoid movements observed in human 
beings. This working hypothesis is formulated on the basis of three 
adequately proven facts: a) choreo-athetoid movements are induced in 
a significant number of parkinsonian patients after long-term l-D O PA  
treatment (seelntroduction); b) l-D O PA  orally administered in animals 
induces a highly specific accumulation of dopamine in the caudate 
nucleus (Pletscher, 1969); c) l-D O PA  or dopamine locally applied into 
the caudate nucleus of cats induces movement disorders which are 
strikingly similar to the behavior neurologists have seen in patients 
treated with l-D O PA  and in patients with Huntington’s chorea.
This may have the implication that the enthusiasm of l-D O PA  
treatment has to be tempered: there is no evidence that the intracaudate 
dopamine-level involved in the therapeutic effects is different from the 
intracaudate dopamine-level involved in the side-effects: as mentioned, 
on reaching therapeutic L-DOPA-levels the choreo-athetoid hyperkine­
sias appear in a large number of parkinsonians (Papavasiliou et cd., 1969).
On the other hand, the continuing controversy of l-D O PA  efficacy 
may also be explained on the basis of the striatal oholine-dopamine 
imbalance, the importance of which has been stressed from results of 
several animal studies (Connor, 1966; Arnfred and Randrup, 1967; 
Scheel-Krüger, 1970). Although it is generally accepted that the im­
balance in the normal relationship of dopamine and acetylcholine in 
parkinsonians results from the primary involvement of a deficient 
dopamine-input in the striatum (Hornykiewicz, 1966; Klawans, 1968), 
the antiparkinson activity of anticholinergic drugs (Feldberg, 1945; 
Klawans, 1968), the parkinson-reinforcing activity of cholinesterase 
inhibitors (Duvoisin, 1967) and the ineffectiveness of l-D O PA  in some 
parkinsonians (Klawans, Ilahi and Shenker, 1970b) do not exclude that 
the imbalance in some patients may result from a primary involvement 
of the cholinergic input: in other words, an imbalance resulting from an 
overactivity of the striatal choline system rather than from a deficiency 
of the striatal dopamine system. I t  is reasonable to suggest that l-D O PA  
treatment of these patients always results in an overactivation of the 
dopamine-sensitive sites and, thus, in the chorea-athetoid hyperkinesias. 
However, it remains to bc invcstigatcd whether this occurs in the patients 
which are not alleviated by l-D Ó PA. Summarizing, these considerations 
indicate that fiïrther experience will be required before l-D O PA  can be 
accepted as the most successful drug in the treatment of Parkinson’s 
disease. As a final remark, the described movements induced by locally 
applied l-D O PA  or dopamine support the hypothesis that choreiform 
movements observed in Huntington’s chorea are due to an overactiva­
tion of the dopamine-sensitive sites in the caudate nucleus (Klawans, 
1970a). According to this hypothesis inhibition of the overactivation
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must consequently lead to the suppression of these movements; this 
indicates that dopamine-inhibitors may have some therapeutic valuè in 
Huntington’s chorea.
Indeed, Papavasiliou et al. (1969) reported that «-methyl-DOPA, 
a depletor of catecholamines, induced a significant diminution of these 
movements. On the other hand, cholinesterase inhibitors also induce 
a reduction of the choreiform movements (Aquilonius and Sjöstrom, 1971). 
This again suggests that motor disorders of the basal ganglia result 
from the difference in the absolute activities of dopamine and acetyl- 
choline rather than from the absolute activity of only one of them.
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